Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Trejo-Velasco B, Ridocci-Soriano F, García-González MP, Cubillos-Arango AM, Payá-Soriano R, Fabregat-Andrés Ó. Mean velocity of the pulmonary artery estimated by cardiac magnetic resonance as an early prognostic predictor in heart failure. Med Clin (Barc) 2019;153:232-238. [PMID: 30795907 DOI: 10.1016/j.medcli.2018.12.011] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2018] [Revised: 12/06/2018] [Accepted: 12/13/2018] [Indexed: 12/22/2022]

For:	Trejo-Velasco B, Ridocci-Soriano F, García-González MP, Cubillos-Arango AM, Payá-Soriano R, Fabregat-Andrés Ó. Mean velocity of the pulmonary artery estimated by cardiac magnetic resonance as an early prognostic predictor in heart failure. Med Clin (Barc) 2019;153:232-238. [PMID: 30795907 DOI: 10.1016/j.medcli.2018.12.011] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2018] [Revised: 12/06/2018] [Accepted: 12/13/2018] [Indexed: 12/22/2022]

Number

Cited by Other Article(s)

Trejo-Velasco B, Cruz-González I, Barreiro-Pérez M, Díaz-Peláez E, García-González P, Martín-García A, Eiros R, Merchán-Gómez S, Pérez del Villar C, Fabregat-Andrés O, Ridocci-Soriano F, Sánchez PL. Mean Velocity of the Pulmonary Artery as a Clinically Relevant Prognostic Indicator in Patients with Heart Failure with Preserved Ejection Fraction. J Clin Med 2022;11:jcm11030491. [PMID: 35159943 PMCID: PMC8836987 DOI: 10.3390/jcm11030491] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2021] [Revised: 01/10/2022] [Accepted: 01/14/2022] [Indexed: 11/18/2022] Open

Affiliation(s)

Blanca Trejo-Velasco Cardiology Department, University Hospital of Salamanca, Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain; (I.C.-G.); (M.B.-P.); (E.D.-P.); (A.M.-G.); (R.E.); (S.M.-G.); (C.P.d.V.); (P.L.S.) Correspondence: or
Ignacio Cruz-González Cardiology Department, University Hospital of Salamanca, Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain; (I.C.-G.); (M.B.-P.); (E.D.-P.); (A.M.-G.); (R.E.); (S.M.-G.); (C.P.d.V.); (P.L.S.) Biomedical Research Networking Center on Cardiovascular Diseases (CIBERCV), 28029 Madrid, Spain
Manuel Barreiro-Pérez Cardiology Department, University Hospital of Salamanca, Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain; (I.C.-G.); (M.B.-P.); (E.D.-P.); (A.M.-G.); (R.E.); (S.M.-G.); (C.P.d.V.); (P.L.S.) Cardiology Department, University Hospital Alvaro Cunqueiro, 36213 Vigo, Spain
Elena Díaz-Peláez Cardiology Department, University Hospital of Salamanca, Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain; (I.C.-G.); (M.B.-P.); (E.D.-P.); (A.M.-G.); (R.E.); (S.M.-G.); (C.P.d.V.); (P.L.S.) Biomedical Research Networking Center on Cardiovascular Diseases (CIBERCV), 28029 Madrid, Spain
Pilar García-González Cardiac Magnetic Resonance Imaging Unit, ASCIRES, 46015 Valencia, Spain;
Ana Martín-García Cardiology Department, University Hospital of Salamanca, Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain; (I.C.-G.); (M.B.-P.); (E.D.-P.); (A.M.-G.); (R.E.); (S.M.-G.); (C.P.d.V.); (P.L.S.) Biomedical Research Networking Center on Cardiovascular Diseases (CIBERCV), 28029 Madrid, Spain
Rocío Eiros Cardiology Department, University Hospital of Salamanca, Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain; (I.C.-G.); (M.B.-P.); (E.D.-P.); (A.M.-G.); (R.E.); (S.M.-G.); (C.P.d.V.); (P.L.S.) Biomedical Research Networking Center on Cardiovascular Diseases (CIBERCV), 28029 Madrid, Spain
Soraya Merchán-Gómez Cardiology Department, University Hospital of Salamanca, Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain; (I.C.-G.); (M.B.-P.); (E.D.-P.); (A.M.-G.); (R.E.); (S.M.-G.); (C.P.d.V.); (P.L.S.) Biomedical Research Networking Center on Cardiovascular Diseases (CIBERCV), 28029 Madrid, Spain
Candelas Pérez del Villar Cardiology Department, University Hospital of Salamanca, Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain; (I.C.-G.); (M.B.-P.); (E.D.-P.); (A.M.-G.); (R.E.); (S.M.-G.); (C.P.d.V.); (P.L.S.) Biomedical Research Networking Center on Cardiovascular Diseases (CIBERCV), 28029 Madrid, Spain
Oscar Fabregat-Andrés Cardiology Department, IMED Hospital of Valencia, 46100 Burjassot, Spain;
Francisco Ridocci-Soriano Cardiology Department, General University Hospital of Valencia, 46014 Valencia, Spain; Department of Medicine, University of Valencia, 46010 Valencia, Spain
Pedro L. Sánchez Cardiology Department, University Hospital of Salamanca, Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain; (I.C.-G.); (M.B.-P.); (E.D.-P.); (A.M.-G.); (R.E.); (S.M.-G.); (C.P.d.V.); (P.L.S.) Biomedical Research Networking Center on Cardiovascular Diseases (CIBERCV), 28029 Madrid, Spain

Collapse

Trejo-Velasco B, Fabregat-Andrés Ó, García-González PM, Perdomo-Londoño DC, Cubillos-Arango AM, Ferrando-Beltrán MI, Belchi-Navarro J, Pérez-Boscá JL, Payá-Serrano R, Ridocci-Soriano F. Prognostic value of mean velocity at the pulmonary artery estimated by cardiovascular magnetic resonance as a prognostic predictor in a cohort of patients with new-onset heart failure with reduced ejection fraction. J Cardiovasc Magn Reson 2020;22:28. [PMID: 32354373 PMCID: PMC7191770 DOI: 10.1186/s12968-020-00621-3] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2019] [Indexed: 11/24/2022] Open

Abstract

BACKGROUND

Pulmonary hypertension (PH) conveys a worse prognosis in heart failure (HF), in particular when right ventricular (RV) dysfunction ensues. Cardiovascular magnetic resonance (CMR) non-invasively estimates pulmonary vascular resistance (PVR), which has shown prognostic value in HF. Importantly, RV to pulmonary artery (PA) coupling is altered early in HF, before significant rise in PV resistance occurs. The aim of this study was to assess the prognostic value of mean velocity at the pulmonary artery (mvPA), a novel non-invasive parameter determined by CMR, in HF with reduced ejection fraction (HFrEF) with and without associated PH.

METHODS

Prospective inclusion of 238 patients admitted for new-onset HFrEF. MvPA was measured with CMR during index admission. The primary endpoint was defined as a composite of HF readmissions and all-cause mortality.

RESULTS

During a median follow-up of 25 months, 91 patients presented with the primary endpoint. Optimal cut-off value of mvPA calculated by the receiver operator curve for the prediction of the primary endpoint was 9 cm/s. The primary endpoint occurred more frequently in patients with mvPA≤9 cm/s, as indicated by Kaplan-Meier survival curves; Log Rank 16.0, p < 0.001. Importantly, mvPA maintained its prognostic value regardless of RV function and also when considering mortality and HF readmissions separately. On Cox proportional hazard analysis, reduced mvPA≤9 cm/s emerged as an independent prognostic marker, together with NYHA III-IV/IV class, stage 3-4 renal failure and ischemic cardiomyopathy.

CONCLUSIONS

In our HFrEF cohort, mvPA emerged as an independent prognostic indicator independent of RV function, allowing identification of a higher-risk population before structural damage onset. Moreover, mvPA emerged as a surrogate marker of the RV-PA unit coupling status.

Collapse